Walgreens Holding (WBA) Stock Price

Walgreens Holding Price

🇺🇸NASDAQ·CLOSED
12.05USD
Market closed
Today +/-
Today %

Walgreens Holding (WBA) Stock | ISIN US9314271084 | WKN A12HJF. The current Walgreens Holding stock price is 12.05 USD (2026). Revenue is 158.57 B USD. Net income is 1.35 B USD. The P/E ratio is 7.71. Market capitalization is 10.4 B USD. Walgreens Holding operates in the Non-cyclical consumption sector.

Walgreens Holding stock price

Ex-Dividend
Details

Stock Price

How to Read This Chart

This chart tracks the historical stock price of Walgreens Holding over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Walgreens Holding stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Walgreens Holding's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Walgreens Holding Stock Price History
DateWalgreens Holding Price
Access this data via the Eulerpool API

Walgreens Holding Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2005
42.2 B USD
2.42 B USD
1.56 B USD
Jan 1, 2006
47.41 B USD
2.7 B USD
1.75 B USD
Jan 1, 2007
53.76 B USD
3.15 B USD
2.04 B USD
Jan 1, 2008
59.03 B USD
3.45 B USD
2.16 B USD
Jan 1, 2009
63.34 B USD
3.51 B USD
2.01 B USD
Jan 1, 2010
67.42 B USD
3.63 B USD
2.09 B USD
Jan 1, 2011
72.18 B USD
4.1 B USD
2.71 B USD
Jan 1, 2012
71.63 B USD
3.51 B USD
2.13 B USD
Jan 1, 2013
72.22 B USD
3.61 B USD
2.55 B USD
Jan 1, 2014
76.39 B USD
3.74 B USD
1.93 B USD
Jan 1, 2015
103.44 B USD
4.74 B USD
4.22 B USD
Jan 1, 2016
117.35 B USD
6.92 B USD
4.17 B USD
Jan 1, 2017
118.21 B USD
6.97 B USD
4.08 B USD
Jan 1, 2018
131.54 B USD
7.33 B USD
5.02 B USD
Jan 1, 2019
120.07 B USD
6.11 B USD
3.98 B USD

Walgreens Holding Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jun 10, 2026, 1:58 PM
 
REVENUE (M USD)
REVENUE GROWTH (%)
GROSS MARGIN (%)
GROSS INCOME (M USD)
NET INCOME (M USD)
NET INCOME GROWTH (%)
DIV. (USD)
DIV. GROWTH (%)
SHARES (M)
DOCUMENTS
Details

Income Statement Key Figures

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Walgreens Holding generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Walgreens Holding retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Walgreens Holding's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Walgreens Holding has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Walgreens Holding's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Walgreens Holding stock margins

The Walgreens Holding margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Walgreens Holding. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Walgreens Holding.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2005
27.93 %
5.74 %
3.7 %
Jan 1, 2006
27.78 %
5.7 %
3.69 %
Jan 1, 2007
28.35 %
5.86 %
3.8 %
Jan 1, 2008
28.19 %
5.85 %
3.65 %
Jan 1, 2009
27.96 %
5.55 %
3.17 %
Jan 1, 2010
28.21 %
5.38 %
3.1 %
Jan 1, 2011
28.39 %
5.69 %
3.76 %
Jan 1, 2012
28.4 %
4.89 %
2.97 %
Jan 1, 2013
29.24 %
4.99 %
3.53 %
Jan 1, 2014
28.23 %
4.9 %
2.53 %
Jan 1, 2015
26.03 %
4.58 %
4.08 %
Jan 1, 2016
25.46 %
5.89 %
3.56 %
Jan 1, 2017
24.67 %
5.89 %
3.45 %
Jan 1, 2018
23.41 %
5.57 %
3.82 %
Jan 1, 2019
23.45 %
5.09 %
3.32 %

Walgreens Holding Stock Revenue, EBIT, Earnings per Share

The Walgreens Holding earnings per share therefore indicates how much revenue Walgreens Holding has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2005
41.05 USD
2.36 USD
1.52 USD
Jan 1, 2006
46.51 USD
2.65 USD
1.72 USD
Jan 1, 2007
53.44 USD
3.13 USD
2.03 USD
Jan 1, 2008
59.27 USD
3.47 USD
2.17 USD
Jan 1, 2009
63.89 USD
3.54 USD
2.02 USD
Jan 1, 2010
68.25 USD
3.67 USD
2.12 USD
Jan 1, 2011
78.08 USD
4.44 USD
2.94 USD
Jan 1, 2012
81.39 USD
3.98 USD
2.42 USD
Jan 1, 2013
75.6 USD
3.78 USD
2.67 USD
Jan 1, 2014
79.15 USD
3.88 USD
2 USD
Jan 1, 2015
98.15 USD
4.5 USD
4 USD
Jan 1, 2016
107.55 USD
6.34 USD
3.82 USD
Jan 1, 2017
109.61 USD
6.46 USD
3.78 USD
Jan 1, 2018
132.2 USD
7.36 USD
5.05 USD
Jan 1, 2019
130.02 USD
6.62 USD
4.31 USD

Walgreens Holding business model & stock analysis

Walgreens Boots Alliance Inc is a global leader in the health and wellness industry. The company's history dates back to 1901 when Charles R. Walgreen began operating a pharmacy in Chicago. Since then, the company has steadily grown and expanded, eventually merging with Alliance Boots in 2014 to become Walgreens Boots Alliance. The business model of Walgreens Boots Alliance focuses on creating a seamless and integrated experience for customers and patients in all areas of healthcare. The company offers a wide range of products and services, including prescription medications, pharmacy and healthcare services, beauty products, vitamins and supplements, photo processing, and more. Walgreens Boots Alliance operates in three main divisions: retail, pharmaceutical wholesale, and pharmaceutical development and manufacturing. In the retail sector, the company operates over 21,000 pharmacies in 11 countries, including the United States, the United Kingdom, Mexico, and China. The pharmacies offer a wide selection of prescription and over-the-counter medications, as well as health and wellness products. Additionally, Walgreens Boots Alliance operates a number of online platforms and mobile applications designed to provide customers with easy access to medication and healthcare services. In the pharmaceutical wholesale division, the company provides services to pharmaceutical companies, hospitals, and retailers. Walgreens Boots Alliance is the largest pharmaceutical wholesaler in the United States and Europe. The company also operates a number of specialized units that focus on the distribution of medications for specific medical needs and therapies. In the pharmaceutical development and manufacturing division, the company is primarily involved in the production and development of generic and specialty medications. This division also includes research and development of new medications targeting the treatment of serious diseases. The products offered by Walgreens Boots Alliance are diverse and cover a wide range of health and wellness needs. The company is particularly known for its wide selection of medications and pharmacy products, including prescription and over-the-counter medications, as well as supplements and vitamins. In the beauty sector, the company offers a wide range of cosmetic products, skincare products, hair care products, and perfumes. Additionally, Walgreens Boots Alliance also offers photo products, such as photo processing and personalized photo books. Walgreens Boots Alliance is also highly committed to promoting healthcare and public health. The company has established partnerships with various nonprofit organizations and universities to support community health programs and improve healthcare. Overall, Walgreens Boots Alliance has become one of the leading companies in the global health industry. With its wide range of products and services and strong market presence, the company aims to provide customers and patients with a comprehensive and integrated experience in all areas of healthcare.

Walgreens Holding SWOT Analysis

Strengths

Walgreens Boots Alliance Inc has several strengths that contribute to its success in the market. Firstly, the company benefits from its extensive retail network, consisting of thousands of stores across multiple countries. This widespread presence enables it to reach a large customer base and establish itself as a leading retail pharmacy chain. Additionally, Walgreens Boots Alliance Inc enjoys strong brand recognition and customer loyalty, which further solidifies its market position.

Furthermore, the company has a well-established supply chain and distribution network, allowing it to efficiently manage its inventory and deliver products to its stores. This operational efficiency enhances its ability to meet customer demands and ensures a smooth shopping experience. Moreover, Walgreens Boots Alliance Inc's strategic partnerships with various healthcare providers and insurance companies contribute to its strength in the industry, as it enables collaboration and drives customer engagement.

Weaknesses

Despite its strengths, Walgreens Boots Alliance Inc also faces certain weaknesses that need to be addressed. One notable weakness is the company's dependency on third-party suppliers for a significant portion of its inventory. This reliance exposes the company to potential disruptions in the supply chain and could impact its ability to meet customer demands. Additionally, Walgreens Boots Alliance Inc may face challenges in effectively integrating acquired companies and implementing consistent business practices across its subsidiaries.

Another weakness lies in Walgreens Boots Alliance Inc's dependence on prescription drugs for a significant portion of its revenue. Any changes in healthcare policies or reimbursement rates could negatively impact the company's financial performance. Moreover, intense competition within the retail pharmacy industry poses a challenge for Walgreens Boots Alliance Inc, as it needs to continually differentiate itself to retain and attract customers.

Opportunities

Walgreens Boots Alliance Inc has several opportunities that can be leveraged for growth and expansion. One such opportunity lies in the rising demand for healthcare services and products due to an aging population and increasing healthcare awareness. The company can capitalize on this trend by expanding its healthcare offerings, such as offering more specialized services and solutions, to attract a larger customer base and increase revenue.

Additionally, the rapid growth of e-commerce presents an opportunity for Walgreens Boots Alliance Inc to enhance its online presence and develop innovative digital solutions to meet customer needs. By investing in technology and improving its online platforms, the company can tap into the growing online retail market and improve customer convenience and satisfaction.

Threats

Walgreens Boots Alliance Inc faces several threats that could impact its market position and performance. Firstly, regulatory changes in the healthcare industry, including modifications in drug pricing and reimbursement policies, can have a significant impact on the company's profitability. These changes can result in reduced profit margins and increased operational costs, potentially affecting its financial stability.

Furthermore, intense competition from both traditional retailers and e-commerce giants poses a threat to Walgreens Boots Alliance Inc. To stay competitive, the company needs to continuously innovate and adapt to changing consumer preferences and shopping habits. Failure to do so may result in loss of market share and reduced revenue. Additionally, economic downturns and fluctuations can negatively impact consumer spending patterns, affecting the company's overall sales and profitability.

Walgreens Holding Segments

Walgreens Holding Revenue by Segment (1/2)

  • 3 Years

  • 5 Years

  • 10 Years

  • Max

Retail Pharmacy USA
Identifies division of a component of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity
Pharmaceutical Wholesale
Retail Pharmacy International
Details
Date
Retail Pharmacy USA
Identifies division of a component of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity
Pharmaceutical Wholesale
Retail Pharmacy International
Jan 1, 2015
0 USD
-1.64 B USD
0 USD
0 USD
Jan 1, 2016
0 USD
2.28 B USD
0 USD
0 USD
Jan 1, 2017
87.3 B USD
0 USD
21.19 B USD
11.81 B USD
Jan 1, 2018
98.39 B USD
0 USD
20.86 B USD
12.28 B USD

Walgreens Holding Revenue by Segment (2/2)

  • 3 Years

  • 5 Years

  • 10 Years

  • Max

Identifies division of a component of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity
Details
Date
Identifies division of a component of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity
Jan 1, 2015
1.51 B USD
Jan 1, 2016
83.8 B USD
Jan 1, 2017
0 USD
Jan 1, 2018
0 USD

Walgreens Holding Revenue by Region

  • 3 Years

  • 5 Years

  • 10 Years

  • Max

United States
United States of America
Europe
Europe (excluding the United Kingdom)
Germany
United Kingdom
Refers to other segment member
Other Countries
Details
Date
United States
United States of America
Europe
Europe (excluding the United Kingdom)
Germany
United Kingdom
Refers to other segment member
Other Countries
Jan 1, 2015
0 USD
0 USD
0 USD
0 USD
0 USD
9.24 B USD
1.83 B USD
0 USD
Jan 1, 2016
0 USD
0 USD
16.79 B USD
0 USD
0 USD
14.08 B USD
2.68 B USD
0 USD
Jan 1, 2017
0 USD
87.3 B USD
0 USD
16.22 B USD
0 USD
12.55 B USD
0 USD
2.14 B USD
Jan 1, 2018
0 USD
0 USD
0 USD
0 USD
0 USD
0 USD
0 USD
2.25 B USD
Jan 1, 2019
0 USD
0 USD
0 USD
0 USD
0 USD
0 USD
0 USD
2.6 B USD
Jan 1, 2020
0 USD
0 USD
0 USD
0 USD
0 USD
0 USD
0 USD
2.47 B USD
Jan 1, 2021
112.01 B USD
0 USD
0 USD
0 USD
10.47 B USD
8.3 B USD
0 USD
1.73 B USD
Jan 1, 2022
110.87 B USD
0 USD
0 USD
0 USD
11.18 B USD
8.89 B USD
0 USD
1.76 B USD
Jan 1, 2023
116.88 B USD
0 USD
0 USD
0 USD
11.21 B USD
8.98 B USD
0 USD
2 B USD
Jan 1, 2024
124.18 B USD
0 USD
0 USD
0 USD
12.07 B USD
9.55 B USD
0 USD
1.86 B USD

Walgreens Holding Eulerpool Fair Value

Walgreens Holding historical P/E ratio, EBIT multiple, and P/S ratio

Walgreens Holding annual returns

Details

Annual Return

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Walgreens Holding shares outstanding

The number of shares was Walgreens Holding in 2025 — This indicates how many shares 863.1 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2005
1.03 B base_Shares
Jan 1, 2006
1.02 B base_Shares
Jan 1, 2007
1.01 B base_Shares
Jan 1, 2008
996 M base_Shares
Jan 1, 2009
991.33 M base_Shares
Jan 1, 2010
987.9 M base_Shares
Jan 1, 2011
924.5 M base_Shares
Jan 1, 2012
880.1 M base_Shares
Jan 1, 2013
955.2 M base_Shares
Jan 1, 2014
965.2 M base_Shares
Jan 1, 2015
1.05 B base_Shares
Jan 1, 2016
1.09 B base_Shares
Jan 1, 2017
1.08 B base_Shares
Jan 1, 2018
995 M base_Shares
Jan 1, 2019
923.5 M base_Shares

Walgreens Holding Dividend History

35 years of dividend payments

YearAnnual DividendYoY ChangePayments
20241USD 47.9%
20231.92USD 0.3%
20221.92USD 1.3%
20211.89USD 2.2%
20201.85USD 3.1%
20191.8USD 6.8%
20181.68USD 8.4%
20171.55USD 5.4%
20161.47USD 5.4%
20151.4USD 6.9%

Walgreens Holding dividend history and estimates

In 2025, Walgreens Holding paid a dividend amounting to 1.66 USD. Dividend means that Walgreens Holding distributes a portion of its profits to its owners.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2005
0.24 USD
0 USD
Jan 1, 2006
0.29 USD
0 USD
Jan 1, 2007
0.35 USD
0 USD
Jan 1, 2008
0.42 USD
0 USD
Jan 1, 2009
0.5 USD
0 USD
Jan 1, 2010
0.63 USD
0 USD
Jan 1, 2011
0.8 USD
0 USD
Jan 1, 2012
1 USD
0 USD
Jan 1, 2013
1.18 USD
0 USD
Jan 1, 2014
1.31 USD
0 USD
Jan 1, 2015
1.4 USD
0 USD
Jan 1, 2016
1.47 USD
0 USD
Jan 1, 2017
1.55 USD
0 USD
Jan 1, 2018
1.68 USD
0 USD
Jan 1, 2019
1.8 USD
0 USD

Walgreens Holding dividend payout ratio

In 2025, Walgreens Holding had a payout ratio of 93.11%. The payout ratio indicates the percentage of the company's profits that Walgreens Holding distributes as dividends.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2005
15.46 %
Jan 1, 2006
16.57 %
Jan 1, 2007
17 %
Jan 1, 2008
19.12 %
Jan 1, 2009
24.75 %
Jan 1, 2010
29.48 %
Jan 1, 2011
27.21 %
Jan 1, 2012
41.32 %
Jan 1, 2013
44.36 %
Jan 1, 2014
65.25 %
Jan 1, 2015
34.88 %
Jan 1, 2016
38.48 %
Jan 1, 2017
41.01 %
Jan 1, 2018
33.33 %
Jan 1, 2019
41.65 %
Price targets and forecasts for Walgreens Holding are not yet available.

Walgreens Holding Earnings Estimates

Walgreens Holding Earnings Estimates

DateEPS estimateRevenue EstimateQuarterly report
6/24/20260.31USD39.55 BUSD2026 Q3
4/6/20260.58USD39.28 BUSD2026 Q2
1/8/20260.45USD39.11 BUSD2026 Q1
6/25/20240.93USD36.16 BUSD2024 Q3
3/26/20240.98USD36.2 BUSD2024 Q2
1/3/20241.15USD35.85 BUSD2024 Q1
6/28/20231.09USD33.67 BUSD2023 Q3
3/29/20231.24USD33.46 BUSD2023 Q2
1/4/20231.14USD33.33 BUSD2023 Q1
10/13/20220.78USD32.57 BUSD2022 Q4
...

EESG©

Eulerpool ESG Scorecard© for the Walgreens Holding stock

84/100
84
Environment
90
Social
77
Governance
E

Environment

20
Scope 1 - Direct Emissions309,000
Scope 2 - Indirect emissions from purchased energy1,081,000
Scope 3 - Indirect emissions within the value chain79,000
Total CO₂ emissions1,390,000
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees71
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees46
White Management Share57
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Walgreens Holding shareholder structure

% Name
9.61098%
The Vanguard Group, Inc.
The Vanguard Group, Inc.
6.95875%
Silver Point Capital, L.P.
Silver Point Capital, L.P.
4.20176%
BlackRock Institutional Trust Company, N.A.
BlackRock Institutional Trust Company, N.A.
3.73575%
State Street Investment Management (US)
State Street Investment Management (US)
2.44957%
Invesco Capital Management LLC
Invesco Capital Management LLC
2.38779%
Fidelity Investments Canada ULC
Fidelity Investments Canada ULC
2.22296%
Geode Capital Management, L.L.C.
Geode Capital Management, L.L.C.
2.00126%
Norges Bank Investment Management (NBIM)
Norges Bank Investment Management (NBIM)
1.85429%
Fidelity Management & Research Company LLC
Fidelity Management & Research Company LLC
1.77527%
Charles Schwab Investment Management, Inc.
Charles Schwab Investment Management, Inc.
...

Walgreens Holding Executives and Management Board

SP

Mr. Stefano Pessina

(83)

Director · since 2015

Compensation7.87 M USD
OB

Ms. Ornella Barra

(71)

Chief Operating Officer, International · since 2021

Compensation6.82 M USD
MM

Mr. Manmohan Mahajan

(46)

Global Chief Financial Officer, Executive Vice President

Compensation5.54 M USD
MM

Mr. Mike Motz

Chief Executive Officer

EB

Ms. Elizabeth Burger

(53)

Executive Vice President and Global Chief Human Resources Officer

Walgreens Holding Supply Chain

Frequently asked questions about Walgreens Holding

Walgreens Boots Alliance Inc is primarily present in the United States. With its headquarters in Deerfield, Illinois, the company operates a vast network of retail pharmacy stores under various brand names across all 50 states. Additionally, Walgreens Boots Alliance Inc has an international presence in several countries and regions, including the United Kingdom, Mexico, Colombia, and Chile. Serving millions of customers worldwide, the company aims to provide accessible healthcare and wellness solutions through its extensive global footprint.

All fundamentals and in-depth analysis of Walgreens Holding

Our stock analysis for Walgreens Holding Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Walgreens Holding Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.